- Home
- TNXP vs FNWD Comparison
TNXP vs FNWD Comparison
Compare TNXP & FNWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- FNWD
- Stock Information
- Founded
- TNXP 2007
- FNWD 1994
- Country
- TNXP United States
- FNWD United States
- Employees
- TNXP N/A
- FNWD N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- FNWD Savings Institutions
- Sector
- TNXP Health Care
- FNWD Finance
- Exchange
- TNXP Nasdaq
- FNWD Nasdaq
- Market Cap
- TNXP 173.9M
- FNWD 143.6M
- IPO Year
- TNXP N/A
- FNWD N/A
- Fundamental
- Price
- TNXP $18.49
- FNWD $34.92
- Analyst Decision
- TNXP Buy
- FNWD Buy
- Analyst Count
- TNXP 1
- FNWD 1
- Target Price
- TNXP $70.00
- FNWD $34.00
- AVG Volume (30 Days)
- TNXP 851.8K
- FNWD 31.0K
- Earning Date
- TNXP 11-07-2025
- FNWD 10-28-2025
- Dividend Yield
- TNXP N/A
- FNWD 1.38%
- EPS Growth
- TNXP N/A
- FNWD N/A
- EPS
- TNXP N/A
- FNWD 1.91
- Revenue
- TNXP $9,831,000.00
- FNWD $66,563,999.00
- Revenue This Year
- TNXP $14.79
- FNWD N/A
- Revenue Next Year
- TNXP $933.49
- FNWD $7.77
- P/E Ratio
- TNXP N/A
- FNWD $18.28
- Revenue Growth
- TNXP N/A
- FNWD N/A
- 52 Week Low
- TNXP $6.76
- FNWD $26.12
- 52 Week High
- TNXP $130.00
- FNWD $35.66
- Technical
- Relative Strength Index (RSI)
- TNXP 31.62
- FNWD 71.43
- Support Level
- TNXP $18.53
- FNWD $32.46
- Resistance Level
- TNXP $20.58
- FNWD $34.40
- Average True Range (ATR)
- TNXP 1.09
- FNWD 1.36
- MACD
- TNXP 0.41
- FNWD 0.17
- Stochastic Oscillator
- TNXP 7.04
- FNWD 91.36
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About FNWD Finward Bancorp
Finward Bancorp is a bank holding company, which engages in the provision of financial services. It offers products and services related to Personal Banking, Cash Management, Saving Account, ebanking, Wealth Management, and Insurance Services. It is engaged in the business of attracting deposits from the general public and the origination of loans, mostly upon the security of single-family residences and commercial real estate, construction loans, commercial business loans, and municipal loans. Geographically, the activities are carried out through the United States.